What is fluctizolam?

Fluctizolam is a new benzodiazepine analog of flubromazolam. It has both anxiolytic and sedative effects. It is believed to have a potency of 10 times that of diazepam. It has a half-life of about 20 hours, which is longer than most benzodiazepines, making it more potent and long-lasting. Its effects are similar to other benzodiazepines, including the ability to induce relaxation, euphoria, and sleep. Due to its potency and long half-life, it is often used in research studies and not yet approved for medical use. The use of fluctizolam can lead to tolerance, addiction, and dependence, making it crucial to use under medical supervision and with a valid prescription. The drug also poses significant risks of overdose and acute respiratory depression. It is classified as a Schedule IV controlled substance in the United States, meaning it has a lower potential for abuse than Schedule II or III substances.